Neuropilin-1 is a placenta growth factor-2 receptor

被引:256
作者
Migdal, M
Huppertz, B
Tessler, S
Comforti, A
Shibuya, M
Reich, R
Baumann, H
Neufeld, G [1 ]
机构
[1] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel
[2] Hebrew Univ Jerusalem, Dept Pharmacol, IL-91120 Jerusalem, Israel
[3] RWTH Aachen, D-52074 Aachen, Germany
[4] Univ Tokyo, Inst Med Sci, Dept Genet, Minato Ku, Tokyo 108, Japan
关键词
D O I
10.1074/jbc.273.35.22272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Placenta growth factor (PIGF) belongs to the family of vascular endothelial growth factors (VEGFs). It binds to the flt-1 VEGF receptor but not to the KDR/flk-1 receptor which is thought to mediate most of the angiogenic and proliferative effects of VEGF, Three PIGF isoforms are produced by alternative splicing. PlGF-1 and PlGF-3 differ from PlGF-2 since they lack the exon 6 encoded peptide which bestows upon PlGF-2 its heparin binding properties. Cross-linking experiments revealed that I-125-PlGF-2 binds to two endothelial cell surface receptors in a heparin dependent fashion. The binding of I-125-PlGF-2 to these receptors was inhibited by an excess of PlGF-2 and by the 165-amino acid form of VEGF (VEGF(165)), but not at all by VEGF(165) and very marginally if at all by PlGF-1, The apparent molecular weight and the binding characteristics of these receptors correspond to those of the recently identified VEGF(165) specific receptor neuropilin-1, and we therefore conclude that neuropilin-1 is a receptor for PlGF-2. The binding of I-125-PlGF-2 as well as the binding of I-125-VEGF(165) to these receptors was inhibited by a synthetic peptide derived from exon 6 of PlGF. Furthermore, the binding of I-125-PIGF-2, but not that of I-125-VEGF(165), was also inhibited by a synthetic peptide derived from exon 7 of PlGF. These observations indicate that the peptides encoded by these exons probably participate in the formation of the domain which mediates the binding of PlGF-2 to these receptors, We have also determined, using chemically modified heparin species, that the presence of sulfate moieties on the glucosamine-O-6 and on the iduronic acid-O-2 groups of heparin was required for the potentiation of I-125-PlGF-2 binding to these receptors. To determine if PlGF-2 is able to induce biological responses that are not induced by PlGF-1, we compared the effects of PlGF-1 and PlGF-2 on the migration and proliferation of endothelial cells. Both PlGF forms induced migration of endothelial cells. However, there was no quantitative difference between the response to PIGF-2 and the response to PIGF-1. Furthermore, neither PIGF-1 nor PlGF-2 had any effect upon the proliferation of the endothelial cells.
引用
收藏
页码:22272 / 22278
页数:7
相关论文
共 48 条
  • [1] NMR SPECTROSCOPIC OBSERVATIONS RELATED TO THE FUNCTION OF SULFATE GROUPS IN HEPARIN - CALCIUM-BINDING VS BIOLOGICAL-ACTIVITY
    AYOTTE, L
    PERLIN, AS
    [J]. CARBOHYDRATE RESEARCH, 1986, 145 (02) : 267 - 277
  • [2] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
    Barleon, B
    Sozzani, S
    Zhou, D
    Weich, HA
    Mantovani, A
    Marme, D
    [J]. BLOOD, 1996, 87 (08) : 3336 - 3343
  • [3] Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing
    Cao, YH
    Ji, WDR
    Qi, P
    Rosin, A
    Cao, YM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) : 493 - 498
  • [4] Heterodimers of placenta growth factor vascular endothelial growth factor - Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR
    Cao, YH
    Chen, H
    Zhou, L
    Chiang, MK
    AnandApte, B
    Weatherbee, JA
    Wang, YD
    Fang, FY
    Flanagan, JG
    Tsang, MLS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) : 3154 - 3162
  • [5] CASU B, 1983, ARZNEIMITTELFORSCH, V33-1, P135
  • [6] The vascular endothelial growth factor receptor Flt-1 mediates biological activities - Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
    Clauss, M
    Weich, H
    Breier, G
    Knies, U
    Rockl, W
    Waltenberger, J
    Risau, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) : 17629 - 17634
  • [7] VEGF(121), A VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ISOFORM LACKING HEPARIN-BINDING ABILITY, REQUIRES CELL-SURFACE HEPARAN SULFATES FOR EFFICIENT BINDING TO THE VEGF RECEPTORS OF HUMAN-MELANOMA CELLS
    COHEN, T
    GITAYGOREN, H
    SHARON, R
    SHIBUYA, M
    HALABAN, R
    LEVI, BZ
    NEUFELD, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) : 11322 - 11326
  • [8] High Levels of Biologically Active Vascular Endothelial Growth Factor (VEGF) are Produced by the Baculovirus Expression System
    Cohen, Tzafra
    Gitay-Goren, Hela
    Neufeld, Gem
    Levi, Ben-Zion
    [J]. GROWTH FACTORS, 1992, 7 (02) : 131 - 138
  • [9] DETHLEFSEN SM, 1994, INVAS METAST, V14, P395
  • [10] THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR
    DEVRIES, C
    ESCOBEDO, JA
    UENO, H
    HOUCK, K
    FERRARA, N
    WILLIAMS, LT
    [J]. SCIENCE, 1992, 255 (5047) : 989 - 991